- Home
- ADN vs NRXS Comparison
ADN vs NRXS Comparison
Compare ADN & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADN
- NRXS
- Stock Information
- Founded
- ADN 2006
- NRXS 2011
- Country
- ADN United States
- NRXS United States
- Employees
- ADN N/A
- NRXS N/A
- Industry
- ADN Power Generation
- NRXS
- Sector
- ADN Utilities
- NRXS
- Exchange
- ADN Nasdaq
- NRXS Nasdaq
- Market Cap
- ADN 7.5M
- NRXS 13.0M
- IPO Year
- ADN N/A
- NRXS 2023
- Fundamental
- Price
- ADN $2.80
- NRXS $2.00
- Analyst Decision
- ADN
- NRXS
- Analyst Count
- ADN 0
- NRXS 0
- Target Price
- ADN N/A
- NRXS N/A
- AVG Volume (30 Days)
- ADN 48.2K
- NRXS 35.0K
- Earning Date
- ADN 12-27-2024
- NRXS 05-12-2025
- Dividend Yield
- ADN N/A
- NRXS N/A
- EPS Growth
- ADN N/A
- NRXS N/A
- EPS
- ADN N/A
- NRXS N/A
- Revenue
- ADN $8,157,000.00
- NRXS $2,685,925.00
- Revenue This Year
- ADN $2,232.99
- NRXS $138,883.78
- Revenue Next Year
- ADN $91.56
- NRXS $118.59
- P/E Ratio
- ADN N/A
- NRXS N/A
- Revenue Growth
- ADN 274.35
- NRXS 9.18
- 52 Week Low
- ADN $1.71
- NRXS $1.33
- 52 Week High
- ADN $8.79
- NRXS $3.78
- Technical
- Relative Strength Index (RSI)
- ADN 47.23
- NRXS 46.19
- Support Level
- ADN $2.49
- NRXS $1.94
- Resistance Level
- ADN $4.00
- NRXS $2.40
- Average True Range (ATR)
- ADN 0.42
- NRXS 0.29
- MACD
- ADN 0.19
- NRXS -0.01
- Stochastic Oscillator
- ADN 44.19
- NRXS 21.43
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).